Plerixafor/G-CSF as Additional Agents for Conditioning Before HSCT in CGD Patients

NCT03547830 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

17

Enrollment

OTHER

Sponsor class

Conditions

Chronic Granulomatous Disease

Interventions

DRUG: Plerixafor
DRUG: Gcsf

Sponsor

Federal Research Institute of Pediatric Hematology, Oncology and Immunology